Compare ARKG and XBI | ETF Tracker

ARKG and XBI, Ranked

Today

FundFeeYieldYTD1 year3 yrs · yr5 yrs · yrWorst dropVolatilityAssetsAvg rank

State Street SPDR S&P Biotech ETFSectors · Health care0.35%0.35%+27.2%+38.1%+34.5%+4.7%−14.9%29.1%$10.5B1.3

ARK Genomic Revolution ETFSectors · Health care0.75%0.00%+70.9%+59.0%+30.6%−8.0%−27.5%45.8%$2.2B1.8

Rank among the two1st → 2ndFee, drop and volatility: lower ranks higherAvg rank: mean of the 8 ranks · 1 is best

End-of-day Nov 3, 2026 · returns include dividends · since: ARKG 2014 · XBI 2006

Head to Head

Swap sides Versus in desk

Head to Head

5Y

ARK Genomic Revolution ETF · $2.2B$6,586

ARKG

XBI

State Street SPDR S&P Biotech ETF · $10.5B$12,576

$10,000 five years ago, dividends reinvested · they hold 12.8% in common

ARKGMeasureXBI

+70.9%Year to dateJan 1 → Nov 3+27.2%

+59.0%1 yearTotal return+38.1%

+30.6%3 years · per year$10,000 became $22,262 · $24,320+34.5%

−8.0%5 years · per year$10,000 became $6,586 · $12,576+4.7%

0.75%Expense ratio$75 · $35 a year on $10k · lower is better0.35%

0.00%Trailing 12-mo yield$0 · $35 a year on $10k0.35%

−27.5%Worst dropSmaller is better−14.9%

45.8%VolatilityLower is calmer29.1%

ARKGXBI Winner of the row, in its colourEach row: the bigger of the two fills its side

2–6XBI wins

End-of-day Nov 3, 2026 · returns include dividends · 3Y and 5Y figures are per-year returns

More Ways to See the Pairs

ARKG vs XBI: Top 5 Holdings

Today

ARKG

35.4%in top 5

XBI

in top 59.7%

ARKGStockXBI

9.8%TEMnot top 5

7.5%TXGnot top 5

7.4%TWST2.0%

5.5%CRSPnot top 5

5.1%GHnot top 5

not top 5MRNA2.4%

not top 5NTRA1.9%

not top 5HALO1.8%

not top 5BIIB1.7%

Held in common12.8%

End-of-day Nov 3, 2026 · share of each fund

ARKG vs XBI Returns, Every Period

5Y

ARKARKG

−8.0%

5 years, per year

XBISPDR

+4.7%

5 years, per year

ARKGXBIFaded: behind in that period

2–2Level

End-of-day Nov 3, 2026 · dividends in · faded = behind in that period

ARKG vs XBI

YTD

ARKARKG

+70.9%

XBISPDR

+27.2%

+70.9%Year to date+27.2%

−27.5%Worst drop · 1Y−14.9%

45.8%Volatility · 1Y29.1%

0.0%Yield0.4%

$2.2BAssets$10.5B

3–1XBI wins

End-of-day Nov 3, 2026 · smaller drop and lower volatility win

Cost, Income and Risk

Fees: ARKG, XBI

Today

0.35%lowest, XBI

FundExpense ratioFee$10k

XBI0.35%$35

ARKG0.75%$75

End-of-day Nov 3, 2026 · fee on $10,000 a year

Yields: ARKG, XBI

1Y

0.35%highest, XBI

FundTrailing yieldYield$10k

XBI0.35%$35

ARKG0.00%$0

End-of-day Nov 3, 2026 · trailing 12-month yield

Income After Fees on $10,000

1Y

$0most kept, XBI

XBI$35 − $35 = $0

ARKG$0 − $75 = −$75

KeptFee

End-of-day Nov 3, 2026 · yield in dollars minus the fee

Overlap: ARKG, XBI

Today

12.8%most shared, ARKG and XBI

ARKGXBI

ARKG—12.8%

XBI12.8%—

End-of-day Nov 3, 2026 · share held in common · outlined: the pair in versus

Return vs Bumpiness: 2 ETFs

1Y

+59.0%ARKG, at 45.8% volatility

XBIWorst drop−14.9%29.1% vol

ARKGWorst drop−27.5%45.8% vol

End-of-day Nov 3, 2026 · up and left is better

Paid More vs Made More

YTD

XBIARKG

+27.2%Year to date+70.9%

0.4%Yield0.0%

+38.1%Past year+59.0%

0.35%Fee0.75%

2–2level

End-of-day Nov 3, 2026

Popular Pairs Near These Two

SCHD vs VIG

YTD

SchwabSCHD

+32.8%

VIGVanguard

+14.0%

+32.8%Year to date+14.0%

3.0%Yield1.5%

$121BAssets$109B

2–0SCHD wins

End-of-day Nov 3, 2026

JEPQ vs JEPI

YTD

J.P. MorganJEPQ

+7.5%

JEPIJ.P. Morgan

+7.0%

+7.5%Year to date+7.0%

12.3%Yield8.0%

$41.8BAssets$46.0B

2–0JEPQ wins

End-of-day Nov 3, 2026

SPYM vs SPY

YTD

SPDRSPYM

+11.5%

SPYSPDR

+11.5%

+11.5%Year to date+11.5%

1.0%Yield1.0%

$185BAssets$798B

0–0level

End-of-day Nov 3, 2026